ALLMedicine™ Hyperhidrosis Center
Research & Reviews 859 results
https://doi.org/10.1111/jdv.18351
Journal of the European Academy of Dermatology and Venere... Henning M, Reguant R et. al.
Jun 24th, 2022 - Research on hyperhidrosis comorbidities has documented the co-occurrence of diseases but has not provided information about temporal disease associations. To investigate the temporal disease trajectories of individuals with hospital diagnosed hype...
https://doi.org/10.1111/dth.15657
Dermatologic Therapy; Zhang Y, Gong YY et. al.
Jun 22nd, 2022 - Axillary osmidrosis(AO) and primary hyperhidrosis(PH) are common diseases, but there are still difficulties in treatment. Microwave therapy may become a new method. To evaluate long-time efficacy of patients with AO or PH treated by microwave. To ...
https://emedicine.medscape.com/article/1122527-treatment
Jun 20th, 2022 - Approach Considerations In dyshidrotic eczema, typical first-line treatment includes high-strength topical steroids and cold compresses. Short courses of oral steroids are the second line of treatment for acute flares, and other immunosuppressants...
https://doi.org/10.1111/jsr.13660
Journal of Sleep Research; Idiaquez J, Casar JC et. al.
Jun 17th, 2022 - Hyperhidrosis is characterized by excessive sweating beyond thermoregulatory needs that affects patients' quality of life. It results from an excessive stimulation of eccrine sweat glands in the skin by the sympathetic nervous system. Hyperhidrosi...
https://emedicine.medscape.com/article/1054257-treatment
Jun 16th, 2022 - Medical Care As no therapeutic studies specific to trichomycosis are available, management strategies mirror erythrasma treatments. [8] Treatment involves alleviating the hyperhidrosis through the use of drying agents. Topical antibiotics containi...
Drugs 71 results see all →
Clinicaltrials.gov 107 results
https://clinicaltrials.gov/ct2/show/NCT03658616
Mar 18th, 2022 - The aim of this study is to investigate the efficacy and safety of 1% GPB cream after 4 weeks of treatment compared with placebo with a sufficient number of patients to obtain statistically significant results, and to assess the long-term safety o...
https://clinicaltrials.gov/ct2/show/NCT05057117
Mar 2nd, 2022 - This trial aims is to assess and compare treatment effect of microwave thermolysis and botulinum toxin A for axillary hyperhidrosis with focus on longevity. The investigators also aim to assess patient satisfaction and adverse reactions in relatio...
https://clinicaltrials.gov/ct2/show/NCT04924036
Feb 10th, 2022 - BACKGROUND: Approximately 1 in 190 people in the United States have experienced a limb amputation. Of these patients with amputations, over sixty percent suffer from hyperhidrosis at the amputation site. Amputation site hyperhidrosis interferes wi...
https://clinicaltrials.gov/ct2/show/NCT03948646
Jan 25th, 2022 - This is a multicenter, randomized, double-blind, vehicle-controlled study to evaluate the safety and efficacy of topically applied sofpironium bromide, 15% gel in subjects with axillary hyperhidrosis. Safety will be assessed through collection of ...
https://clinicaltrials.gov/ct2/show/NCT03836287
Jan 25th, 2022 - This is a multicenter, randomized, double-blind, vehicle-controlled study to evaluate the safety and efficacy of topically applied sofpironium bromide, 15% gel in subjects with axillary hyperhidrosis. Safety will be assessed through collection of ...
News 180 results
https://www.mdedge.com/dermatology/article/255261/aesthetic-dermatology/adhesive-tape-guide-injection-depth-botulinum-toxin
Jamison A. Harvey, MD, David L. Swanson, MD
Jun 7th, 2022 - Practice Gap OnabotulinumtoxinA is a US Food and Drug Administration–approved second-line treatment of axillary hyperhidrosis, with a long-term success rate greater than 80% and minimal adverse effects. 1 The recommended depth and angle of injectio.
https://www.mdedge.com/dermatology/article/255160/dermatologic-surgery/whats-ahead-laser-assisted-drug-delivery
Doug Brunk
Jun 2nd, 2022 - SAN DIEGO – Twelve years ago, Merete Haedersdal, MD, PhD, and colleagues published data from a swine study, which showed for the first time that the ablative fractional laser can be used to boost the uptake of drugs into the skin. That discovery p.
https://www.mdedge.com/familymedicine/article/248633/musculoskeletal-disorders/botulinum-toxin-chronic-pain-whats-horizon
MDedge Family Medicine; Caleb Dickison, DO, CAQSM, Jeffrey C. Leggit, MD, CAQSM
Nov 12th, 2021 - Botulinum toxin (BoNT) was first approved by the US Food and Drug Administration (FDA) for the treatment of strabismus and blepharospasm in 1989. Since then, approved indications have expanded to include spasticity, cervical dystonia, severe axill.
https://www.medscape.com/viewarticle/962552
Nov 9th, 2021 - LOS ANGELES — When Adam Friedman, MD, establishes a diagnosis of hyperhidrosis with patients and informs them that it's a medical condition, sometimes they break down in tears. Dr Adam Friedman "That's because for years they may have been thinking...
https://www.mdedge.com/pediatrics/article/247654/dermatology/teen-boys-knee-lesion-has-changed
Catalina Matiz, MD
Oct 20th, 2021 - A biopsy of the lesion was performed which showed an increased number of eccrine glands and blood vessels within the dermis. Some areas showed an increase in adipocytes and smooth muscle bundles.